People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TP Therapeutics, Inc. | — | Pharmaceuticals | Series B | $18.0M | $611.4M | 2015 |
| Applied BioCode, Inc. | — | Biotechnology | Series A | $17.5M | $334.6M | 2011 |
| RevMAb Biosciences, Inc. | — | Biotechnology | Seed | $6.6M | $104.0M | 2014 |
George J. Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George J. Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dean J. Tsao | 2 | 2 |
| BIHUA CHEN | 1 | 14 |
| George Lee | 1 | 6 |
| Yishan Li | 1 | 4 |
| JINGRONG JEAN CUI | 1 | 2 |
| Yaohuang Ke | 1 | 1 |
| Edward J. Yang | 1 | 1 |
| R. April J. Ho | 1 | 1 |
| Zonh-Zen "Winston" Ho | 1 | 1 |
| Kenneth Jean Fong | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.